In GBM, PME-1 overexpression is found in 44% of cases (n = 222), positively correlating with malignancy (stage), increased Ki-67 proliferation index, and increased ERK and MEK phosphorylation [16], while PME-1 inhibition restricts GBM growth [16, 19]. This evidence concerns the gene MAP2K7 and glioblastoma.